Serum disease-associated proteins of ankylosing spondylitis: results of a preliminary study by comparative proteomics.

@article{Li2010SerumDP,
  title={Serum disease-associated proteins of ankylosing spondylitis: results of a preliminary study by comparative proteomics.},
  author={Tian Li and Zuoan Huang and Ben-rong Zheng and Ze-tao Liao and Li-ke Zhao and Jieruo Gu},
  journal={Clinical and experimental rheumatology},
  year={2010},
  volume={28 2},
  pages={201-7}
}
OBJECTIVES Ankylosing spondylitis (AS) is difficult to diagnose at the early stage since it lacks simple and specific diagnostic indicators. Proteomics is a new enabling technology to screen disease-associated proteins which can be used in diagnostics or therapeutics. This study was performed by using two-dimensional electrophoresis (2-DE) in combination with mass spectrometry to search for disease-associated proteins in the sera of AS patients. METHODS Sera from 6 AS patients and 6 healthy… CONTINUE READING

References

Publications referenced by this paper.
Showing 1-10 of 34 references

SCHELTENS P: Use of proteomic approaches to identify disease biomarkers

  • CE TEUNISSEN
  • Lancet Neurol 2007;
  • 2007
1 Excerpt

Similar Papers

Loading similar papers…